A. Vogel AG
15
0
0
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
20.0%
3 terminated/withdrawn out of 15 trials
78.6%
-7.9% vs industry average
73%
11 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Mental Balance Study
Role: lead
Eschscholzia Study
Role: lead
Sleep Well Observation Study
Role: lead
Echinaforce COVID-19 Shedding Study
Role: lead
Echinaforce Study to Investigate Explorative Pharmacology and Effectiveness to Prevent From Enveloped Virus Infections
Role: lead
Safety and Efficacy of the Sore Throat Lozenges to Treat Acute Sore Throats
Role: lead
Study of Echinaforce Junior Tablets in Children With Acute Colds
Role: lead
Echinacea Junior vs Vitamin C in Children 4-12 Years Old
Role: lead
Superiority of Newly Developed Over Basic Echinacea Formulations for the Treatment of Respiratory Tract Infections
Role: lead
Study to Assess Safety and Efficacy of Nephrosolid Tbs to Stimulate Urinary Output in Non-patient Volunteers
Role: lead
Echinaforce Junior Bioavailability Trial
Role: lead
Efficacy and Safety of Sage Tablets Compared to Placebo in Menopausal Patients With Hot Flushes and Sweating
Role: lead
Echinacea Safety Study
Role: lead
Clinical Study to Assess the Influence of a Saw Palmetto Preparation in Patients With Benign Prostatic Hyperplasia (BPH) and Sexual Dysfunctions
Role: lead
Clinical Trial for Assessment of Safety and Efficacy of a Echinacea/Sage Spray Compared to a Chlorhexidine/Lidocaine Spray in the Treatment of Acute Sore Throats
Role: lead
All 15 trials loaded